ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)

Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer

NCT04352777 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1

NCT00306631 ·Status: COMPLETED ·Phase: PHASE2

Observation of Medical Treatments in MBC HER2-negative Patients

NCT02365831 ·Status: UNKNOWN

To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer

NCT04660435 ·Status: RECRUITING

ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism

NCT02806817 ·Status: COMPLETED ·Phase: EARLY_PHASE1

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

NCT07216105 ·Status: RECRUITING ·Phase: PHASE1

Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients

NCT00432172 ·Status: COMPLETED ·Phase: PHASE2

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

NCT06179303 ·Status: RECRUITING ·Phase: PHASE2

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

NCT02684032 ·Status: COMPLETED ·Phase: PHASE1

Discovering Factors in Metastatic Breast Cancer Patients' Clinical Trial Experiences

NCT05760183 ·Status: NOT_YET_RECRUITING

Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344

NCT00897026 ·Status: COMPLETED

Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

NCT00353483 ·Status: RECRUITING

Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer Patient

NCT00669773 ·Status: UNKNOWN ·Phase: PHASE2

A Study To Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

NCT02616224 ·Status: WITHDRAWN

Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy

NCT04276337 ·Status: UNKNOWN

A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer

NCT00567190 ·Status: COMPLETED ·Phase: PHASE3

Abraxane in Treatment of Metastatic Breast Cancer

NCT02555696 ·Status: COMPLETED

Study of MDX-010 in Stage IV Breast Cancer

NCT00083278 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer

NCT01006785 ·Status: TERMINATED ·Phase: PHASE2

Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer

NCT04993014 ·Status: RECRUITING ·Phase: PHASE2

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

NCT00433407 ·Status: COMPLETED ·Phase: NA

Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

NCT03281902 ·Status: ACTIVE_NOT_RECRUITING

Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer

NCT00256243 ·Status: COMPLETED ·Phase: PHASE2

Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer

NCT00336791 ·Status: COMPLETED ·Phase: PHASE3

Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial

NCT00001250 ·Status: COMPLETED ·Phase: PHASE2